(1)
Cardiac Magnetic Resonance Imaging In The Evaluation Of Patients With Valvular Heart Disease. Journal of Pharmaceutical Negative Results 2023, 1349-1367. https://doi.org/10.47750/pnr.2023.14.02.174.